Clinical trials: Advanced Cirrhosis
Cirrhosis, Portal Hypertension
Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
The aim of this study is to investigate the effects of spironolactone on liver fibrosis progression and portal pressure gradient in patients with advanced chronic liver disease.
- Trial name
- FP-PH (NCT02907749)
- Testing
- Spironolactone and carvedilol, Carvedilol
- Where
- China
- Volunteers
- 96 people
- Sponsor
- Changqing Yang
Advanced Cirrhosis
Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis
The patients will be randomized into two groups 1. Endoscopic Variceal Ligation with Non Selective Beta Blocker 2. Placebo with Endoscopic Variceal Ligation
- Trial name
- NCT02739581
- Testing
- Endoscopic Variceal Ligation, Non selective beta blocker
- Where
- India
- Sponsor
- Institute of Liver and Biliary Sciences, India
Intrahepatic Cholangiocarcinoma (Icc)
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study
Second-line regimen with or without consolidative radiotherapy in patients with oligometastatic/locally advanced unresectable intrahepatic cholangiocarcinoma: an open-label, randomised, controlled study.
- Trial name
- SED-RO-ICC (NCT06946849)
- Testing
- radiotherapy, FOLFIRI or FOLFOX or Regorafenib
- Where
- China
- Volunteers
- 76 people
- Sponsor
- Shanghai Zhongshan Hospital